An overview of molecular mechanism of nephrotic syndrome

International Journal of Nephrology

Volumn 2012, Issue , 2012, Pages

  MacHado, Juliana Reis ^a   Rocha, Laura Penna ^a   Neves, Precil Diego Miranda De Menezes ^a   Cobô, Eliângela De Castro ^a   Silva, Marcos Vinícius ^a   Castellano, Lúcio Roberto ^b   Corrêa, Rosana Rosa Miranda ^a   Reis, Marlene Antônia ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866238648     PISSN: 2090214X     EISSN: 20902158     Source Type: Journal    
DOI: 10.1155/2012/937623     Document Type: Review

References (80)

1. Tryggvason K., Patrakka J., Wartiovaara J., Hereditary proteinuria syndromes and mechanisms of proteinuria. The New England Journal of Medicine 2006 354 13 1387 1401 2-s2.0-33645403170 10.1056/NEJMra052131
2. Schnaper H. W., Kopp J. B., Why kidneys fail: report from an American Society of Nephrology Advances in Research Conference. Journal of the American Society of Nephrology 2006 17 7 1777 1781 2-s2.0-33745825957 10.1681/ASN.2006030267 (Pubitemid 44036160)
3. Pollak M. R., Inherited podocytopathies: FSGS and nephrotic syndrome from a genetic viewpoint. Journal of the American Society of Nephrology 2002 13 12 3016 3023 2-s2.0-0036893492 10.1097/01.ASN.0000039569.34360.5E (Pubitemid 35386922)
4. Jennette J. C., Olson J. L., The nephrotic syndrome. Pathology of the Kidney 2007 Boston, Mass, USA Little Brown 125 205
5. Barisoni L., Schnaper H. W., Kopp J. B., A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clinical Journal of the American Society of Nephrology 2007 2 3 529 542 2-s2.0-34748843166 10.2215/CJN.04121206
6. Shirato I., Podocyte process effacement in vivo. Microscopy Research and Technique 2002 57 4 241 246 2-s2.0-0037093502 10.1002/jemt.10082 (Pubitemid 34553257)
7. Ma H., Togawa A., Soda K., Zhang J., Lee S., Ma M., Yu Z., Ardito T., Czyzyk J., Diggs L., Joly D., Hatakeyama S., Kawahara E., Holzman L., Guan J. L., Ishibe S., Inhibition of podocyte FAK protects against proteinuria and foot process effacement. Journal of the American Society of Nephrology 2010 21 7 1145 1156 2-s2.0-77954599877 10.1681/ASN.2009090991
8. Schumacher V., Schärer K., Wühl E., Altrogge H., Bonzel K. E., Guschmann M., Neuhaus T. J., Pollastro R. M., Kuwertz-Bröking E., Bulla M., Tondera A. M., Mundel P., Helmchen U., Waldherr R., Weirich A., Royer-Pokora B., Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations. Kidney International 1998 53 6 1594 1600 2-s2.0-7144261709 10.1046/j.1523-1755.1998.00948.x (Pubitemid 28243741)
9. Kambham N., Markowitz G. S., Valeri A. M., Lin J., D'Agati V. D., Obesity-related glomerulopathy: an emerging epidemic. Kidney International 2001 59 4 1498 1509 2-s2.0-0035071325 10.1046/j.1523-1755.2001.0590041498.x (Pubitemid 32281241)
10. Kincaid-Smith P., Hypothesis: obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled 'hypertensive nephrosclerosis' Journal of Hypertension 2004 22 6 1051 1055 2-s2.0-2642513115 10.1097/00004872-200406000-00001 (Pubitemid 38720992)
11. Barisoni L., Bruggeman L. A., Mundel P., D'Agati V. D., Klotman P. E., HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney International 2000 58 1 173 181 2-s2.0-0033947637 10.1046/j.1523-1755.2000.00152.x (Pubitemid 30429862)
12. Bariéty J., Nochy D., Mandet C., Jacquot C., Glotz D., Meyrier A., Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy. Kidney International 1998 53 4 918 925 2-s2.0-0031970078 10.1111/j.1523-1755.1998.00845.x (Pubitemid 28155664)
13. Donoviel D. B., Freed D. D., Vogel H., Potter D. G., Hawkins E., Barrish J. P., Mathur B. N., Turner C. A., Geske R., Montgomery C. A., Starbuck M., Brandt M., Gupta A., Ramirez-Solis R., Zambrowicz B. P., Powell D. R., Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN. Molecular and Cellular Biology 2001 21 14 4829 4836 2-s2.0-0034948819 10.1128/MCB.21.14.4829-4836.2001 (Pubitemid 32588261)
14. Shih N. Y., Li J., Karpitskii V., Nguyen A., Dustin M. L., Kanagawa O., Miner J. H., Shaw A. S., Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 1999 286 5438 312 315 2-s2.0-0033536599 10.1126/science.286.5438.312 (Pubitemid 29484698)
15. Shaw A. S., Miner J. H., CD2-associated protein and the kidney. Current Opinion in Nephrology and Hypertension 2001 10 1 19 22 10.1097/00041552- 200101000-00004 (Pubitemid 32102218)
16. Ciani L., Patel A., Allen N. D., Ffrench-Constant C., Mice lacking the giant protocadherin mFAT1 exhibit renal slit junction abnormalities and a partially penetrant cyclopia and anophthalmia phenotype. Molecular and Cellular Biology 2003 23 10 3575 3582 2-s2.0-0038641811 10.1128/MCB.23.10.3575-3582.2003 (Pubitemid 36539190)
17. Boute N., Gribouval O., Roselli S., NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nature Genetics 2000 24 4 349 354 (Pubitemid 30187431)
18. Tsukaguchi H., Sudhakar A., Le T. C., Nguyen T., Yao J., Schwimmer J. A., Schachter A. D., Poch E., Abreu P. F., Appel G. B., Pereira A. B., Kalluri R., Pollak M. R., NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. Journal of Clinical Investigation 2002 110 11 1659 1666 2-s2.0-0036897388 10.1172/JCI200216242 (Pubitemid 35424244)
19. Koziell A., Grech V., Hussain S., Lee G., Lenkkeri U., Tryggvason K., Scambler P., Genotype/phenotype correlations of NPHS1 and NPHS2 mutations in nephrotic syndrome advocate a functional inter-relationship in glomerular filtration. Human Molecular Genetics 2002 11 4 379 388 2-s2.0-0037084569 (Pubitemid 34213611)
20. Zhu L., Yu L., Wang C. D., Lv J. C., Li G. S., Zhang H., Wang H. Y., Genetic effect of the NPHS2 gene variants on proteinuria in minimal change disease and immunoglobulin A nephropathy. Nephrology 2009 14 8 728 734 2-s2.0-71449091932 10.1111/j.1440-1797.2009.01109.x
21. Smoyer W. E., Mundel P., Gupta A., Welsh M. J., Podocyte α -actinin induction precedes foot process effacement in experimental nephrotic syndrome. American Journal of Physiology 1997 273 1 F150 F157 2-s2.0-0030764235
22. Kerjaschki D., Sharkey D. J., Farquhar M. G., Identification and characterization of podocalyxinthe major sialoprotein of the renal glomerular epithelial cell. Journal of Cell Biology 1984 98 4 1591 1596 2-s2.0-0021262325 (Pubitemid 14126988)
23. Thomas P. E., Wharram B. L., Goyal M., Wiggins J. E., Holzman L. B., Wiggins R. C., GLEPP1, a renal glomerular epithelial cell (podocyte) membrane protein- tyrosine phosphatase. Identification, molecular cloning, and characterization in rabbit. The Journal of Biological Chemistry 1994 269 31 19953 19962 2-s2.0-0028167598
24. Wharram B. L., Goyal M., Gillespie P. J., Wiggins J. E., Kershaw D. B., Holzman L. B., Dysko R. C., Saunders T. L., Samuelson L. C., Wiggins R. C., Altered podocyte structure in GLEPP1 (Ptpro)-deficient mice associated with hypertension and low glomerular filtration rate. Journal of Clinical Investigation 2000 106 10 1281 1290 2-s2.0-0033722475
25. Barisoni L., Kriz W., Mundel P., D'Agati V., The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. Journal of the American Society of Nephrology 1999 10 1 51 61 2-s2.0-0032929050 (Pubitemid 29034942)
26. Kavoura E., Gakiopoulou H., Paraskevakou H., Marinaki S., Agrogiannis G., Stofas A., Boletis I., Patsouris E., Lazaris A. C., Immunohistochemical evaluation of podocalyxin expression in glomerulopathies associated with nephrotic syndrome. Human Pathology 2011 42 2 227 235 2-s2.0-78751591370 10.1016/j.humpath.2010.05.028
27. Yap H. K., Cheung W., Murugasu B., Sim S. K., Seah C. C., Jordan S. C., Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. Journal of the American Society of Nephrology 1999 10 3 529 537 2-s2.0-0033052190 (Pubitemid 29117634)
28. Le Berre L., Hervé C., Buzelen F., Usal C., Soulillou J. P., Dantal J., Renal macrophage activation and Th2 polarization precedes the development of nephrotic syndrome in Buffalo/Mna rats. Kidney International 2005 68 5 2079 2090 2-s2.0-30944431921 10.1111/j.1523-1755.2005.00664.x (Pubitemid 43117782)
29. Lai K. W., Wei C. L., Tan L. K., Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. Journal of the American Society of Nephrology 2007 18 5 1476 1485
30. Pereira R. L., Reis V. O., Semedo P., Invariant natural killer T cell agonist modulates experimental focal and segmental glomerulosclerosis. PLoS ONE 2012 7 3 e32454 10.1371/journal.pone.0032454
31. Mesnard L., Keller A. D. C., Michel M. L., Vandermeersch S., Rafat C., Letavernier E., Tillet Y., Rondeau E., Leite-de-Moraes M. C., Invariant natural killer T cells and TGF- β attenuate anti-GBM glomerulonephritis. Journal of the American Society of Nephrology 2009 20 6 1282 1292 2-s2.0-67449108192 10.1681/ASN.2008040433
32. Border W. A., Ruoslahti E., Transforming growth factor- β 1 induces extracellular matrix formation in glomerulonephritis. Cell Differentiation and Development 1990 32 3 425 431 2-s2.0-0025690614 10.1016/0922-3371(90)90059-6
33. Shankland S. J., Hugo C., Coats S. R., Nangaku M., Pichler R. H., Gordon K. L., Pippin J., Roberts J. M., Couser W. G., Johnson R. J., Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney International 1996 50 4 1230 1239 2-s2.0-10244265941 (Pubitemid 26342814)
34. Shankland S. J., Cell-cycle control and renal disease. Kidney International 1997 52 2 294 308 2-s2.0-0030751147 (Pubitemid 27359571)
35. Schiffer M., Von Gersdorff G., Bitzer M., Susztak K., Bottinger E. P., Smad proteins and transforming growth factor- β signaling. Kidney International, Supplement 2000 58 77 S45 S52 2-s2.0-0033858467
36. Schnaper H. W., Hayashida T., Poncelet A. C., It's a Smad world: regulation of TGF- β signaling in the kidney. Journal of the American Society of Nephrology 2002 13 4 1126 1128 2-s2.0-0036203790 (Pubitemid 34274113)
37. Border W. A., Noble N. A., Transforming growth factor β in tissue fibrosis. The New England Journal of Medicine 1994 331 19 1286 1292 2-s2.0-0028109801 10.1056/NEJM199411103311907 (Pubitemid 24333194)
38. Schiffer M., Bitzer M., Roberts I. S. D., Kopp J. B., Dijke P., Mundel P., Böttinger E. P., Apoptosis in podocytes induced by TGF- β and Smad7. Journal of Clinical Investigation 2001 108 6 807 816 2-s2.0-0034836835 10.1172/JCI200112367 (Pubitemid 32880291)
39. Strehlau J., Schachter A. D., Pavlakis M., Singh A., Tejani A., Strom T. B., Activated intrarenal transcription of CTL-effectors and TGF- β 1 in children with focal segmental glomerulosclerosis. Kidney International 2002 61 1 90 95 2-s2.0-0036149008 10.1046/j.1523-1755.2002.00090.x (Pubitemid 34075134)
40. Li Y., Kang Y. S., Dai C., Kiss L. P., Wen X., Liu Y., Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. American Journal of Pathology 2008 172 2 299 308 2-s2.0-39549098861 10.2353/ajpath.2008.070057 (Pubitemid 351282018)
41. Yamaguchi Y., Iwano M., Suzuki D., Nakatani K., Kimura K., Harada K., Kubo A., Akai Y., Toyoda M., Kanauchi M., Neilson E. G., Saito Y., Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy. American Journal of Kidney Diseases 2009 54 4 653 664 2-s2.0-70349263307 10.1053/j.ajkd.2009.05.009
42. Reidy K., Susztak K., Epithelial-mesenchymal transition and podocyte loss in diabetic kidney disease. American Journal of Kidney Diseases 2009 54 4 590 593 2-s2.0-70349251778 10.1053/j.ajkd.2009.07.003
43. Kang Y. S., Li Y., Dai C., Kiss L. P., Wu C., Liu Y., Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria. Kidney International 2010 78 4 363 373 2-s2.0-77955172248 10.1038/ki.2010.137
44. Kim H. J., Lee H. H., Yoo H. D., Hwa Lee J., Hong S. T., Development of a solid-phase binding assay and identification of nonpeptide ligands for the FynB Src homology 2 domain. Journal of Pharmaceutical and Biomedical Analysis 2002 27 1-2 51 56 2-s2.0-0036027750 10.1016/S0731-7085(01)00507-6 (Pubitemid 33001381)
45. Patrakka J., Tryggvason K., Nephrina unique structural and signaling protein of the kidney filter. Trends in Molecular Medicine 2007 13 9 396 403 2-s2.0-34548526982 10.1016/j.molmed.2007.06.006 (Pubitemid 47385379)
46. Lahdenperä J., Kilpeläinen P., Liu X. L., Pikkarainen T., Reponen P., Ruotsalainen V., Tryggvason K., Clustering-induced tyrosine phosphorylation of nephrin by Src family kinases. Kidney International 2003 64 2 404 413 2-s2.0-0037707376 10.1046/j.1523-1755.2003.00097.x (Pubitemid 36871911)
47. Li H., Zhu J., Aoudjit L., Latreille M., Kawachi H., Larose L., Takano T., Rat nephrin modulates cell morphology via the adaptor protein Nck. Biochemical and Biophysical Research Communications 2006 349 1 310 316 2-s2.0-33748294311 10.1016/j.bbrc.2006.08.053 (Pubitemid 44331794)
48. Blasutig I. M., New L. A., Thanabalasuriar A., Dayarathna T. K., Goudreault M., Quaggin S. E., Li S. S. C., Gruenheid S., Jones N., Pawson T., Phosphorylated YDXV motifs and Nck SH2/SH3 adaptors act cooperatively to induce actin reorganization. Molecular and Cellular Biology 2008 28 6 2035 2046 2-s2.0-40349112977 10.1128/MCB.01770-07 (Pubitemid 351342633)
49. Jones N., New L. A., Fortino M. A., Nck proteins maintain the adult glomerular filtration barrier. Journal of the American Society of Nephrology 2009 20 7 1533 1543 10.1681/ASN.2009010056
50. Andrews P. M., Investigations of cytoplasmic contractile and cytoskeletal elements in the kidney glomerulus. Kidney International 1981 20 5 549 562 2-s2.0-0019820230 (Pubitemid 12207634)
51. Mundel P., Heid H. W., Mundel T. M., Krüger M., Reiser J., Kriz W., Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes. Journal of Cell Biology 1997 139 1 193 204 2-s2.0-0030816323 10.1083/jcb.139.1.193 (Pubitemid 27444091)
52. Kaplan J. M., Kim S. H., North K. N., Rennke H., Correia L. A., Tong H. Q., Mathis B. J., Rodríguez-Pérez J. C., Allen P. G., Beggs A. H., Pollak M. R., Mutations in ACTN4, encoding α -actinin-4, cause familial focal segmental glomerulosclerosis. Nature Genetics 2000 24 3 251 256 2-s2.0-0034051681 10.1038/73456 (Pubitemid 30132192)
53. Srivastava T., Garola R. E., Whiting J. M., Alon U. S., Synaptopodin expression in idiopathic nephrotic syndrome of childhood. Kidney International 2001 59 1 118 125 2-s2.0-0035175276 10.1046/j.1523-1755.2001.00472.x (Pubitemid 32055220)
54. Barisoni L., Mundel P., Podocyte biology and the emerging understanding of podocyte diseases. American Journal of Nephrology 2003 23 5 353 360 2-s2.0-0141569607 10.1159/000072917 (Pubitemid 37116935)
55. Lehtonen S., Zhao F., Lehtonen E., CD2-associated protein directly interacts with the actin cytoskeleton. American Journal of Physiology 2002 283 4 F734 F743 2-s2.0-0036783544 (Pubitemid 35033961)
56. Yuan H., Takeuchi E., Salant D. J., Podocyte slit-diaphragm protein nephrin is linked to the actin cytoskeleton. American Journal of Physiology 2002 282 4 F585 F591 2-s2.0-0036080664 (Pubitemid 34654504)
57. Somlo S., Mundel P., Getting a foothold in nephrotic syndrome. Nature Genetics 2000 24 4 333 335 2-s2.0-0034126357 10.1038/74139 (Pubitemid 30187426)
58. Henry J., Miller M. M., Pontarotti P., Structure and evolution of the extended B7 family. Immunology Today 1999 20 6 285 288 2-s2.0-0033153443 10.1016/S0167-5699(98)01418-2 (Pubitemid 29258166)
59. Henry C. B. S., Duling B. R., Permeation of the luminal capillary glycocalyx is determined by hyaluronan. American Journal of Physiology 1999 277 2 H508 H514 2-s2.0-0032872697 (Pubitemid 29415963)
60. Wakem P., Burns R. P., Ramirez F., Zlotnick D., Ferbel B., Haidaris C. G., Gaspari A. A., Allergens and irritants transcriptionally upregulate CD80 gene expression in human keratinocytes. Journal of Investigative Dermatology 2000 114 6 1085 1092 2-s2.0-0034047409 10.1046/j.1523-1747.2000.00997.x (Pubitemid 30415222)
61. Reiser J., von Gersdorff G., Loos M., Induction of B7-1 in podocytes is associated with nephrotic syndrome. Journal of Clinical Investigation 2004 113 10 1390 1397 (Pubitemid 39071694)
62. Agarwal R., Chronic kidney disease is associated with oxidative stress independent of hypertension. Clinical Nephrology 2004 61 6 377 383 2-s2.0-2942702379 (Pubitemid 38787331)
63. Ong-Ajyooth L., Ong-Ajyooth S., Parichatikanond P., The effect of α -tocopherol on the oxidative stress and antioxidants in idiopathic IgA nephropathy. Journal of the Medical Association of Thailand 2006 89 supplement 5 S164 S170 2-s2.0-33846658072 (Pubitemid 46193146)
64. Kuo H. T., Kuo M. C., Chiu Y. W., Chang J. M., Guh J. Y., Chen H. C., Increased glomerular and extracellular malondialdehyde levels in patients and rats with focal segmental glomerulosclerosis. European Journal of Clinical Investigation 2005 35 4 245 250 2-s2.0-17444416102 10.1111/j.1365-2362.2005. 01488.x (Pubitemid 40546922)
65. Nezhad S. T., Momeni B., Basiratnia M., Glomerular malondialdehyde levels in patients with focal and segmental glomerulosclerosis and minimal change disease. Saudi Journal of Kidney Diseases and Transplantation 2010 21 5 886 891 2-s2.0-79952064861
66. Ronco P., Debiec H., Molecular pathomechanisms of membranous nephropathy: from heymann nephritis to alloimmunization. Journal of the American Society of Nephrology 2005 16 5 1205 1213 2-s2.0-23944525929 10.1681/ASN.2004121080 (Pubitemid 41716505)
67. Rees A., Kain R., A watershed in the understanding of membranous nephropathy. Nature Reviews Nephrology 2009 5 11 617 618 2-s2.0-70350494473 10.1038/nrneph.2009.167
68. Ronco P., Debiec H., Membranous glomerulopathy: the evolving story. Current Opinion in Nephrology and Hypertension 2010 19 3 254 259 2-s2.0-77951485167 10.1097/MNH.0b013e328336eafd
69. Nangaku M., Shankland S. J., Couser W. G., Cellular response to injury in membranous nephropathy. Journal of the American Society of Nephrology 2005 16 5 1195 1204 2-s2.0-23944438985 10.1681/ASN.2004121098 (Pubitemid 41716504)
70. Ronco P., Debiec H., Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men. Seminars in Immunopathology 2007 29 4 445 458 2-s2.0-35948940783 10.1007/s00281-007-0091-2 (Pubitemid 350077262)
71. Glassock R. J., The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey. American Journal of Kidney Diseases 2010 56 1 157 167 2-s2.0-77953684057 10.1053/j.ajkd.2010.01.008
72. Ronco P., Debiec H., Podocyte antigens and glomerular disease. Nephron 2007 107 2 e41 e46 2-s2.0-35048846612 10.1159/000107708 (Pubitemid 47557272)
73. Jefferson J. A., Pippin J. W., Shankland S. J., Experimental models of membranous nephropathy. Drug Discovery Today 2010 7 1-2 27 33 2-s2.0-78650512274 10.1016/j.ddmod.2010.11.001
74. Wu C. C., Chen J. S., Huang C. F., Approaching biomarkers of membranous nephropathy from a murine model to human disease. Journal of Biomedicine and Biotechnology 2011 2011 11 581928 10.1155/2011/581928
75. van Damme B. J. C., Fleuren G. J., Bakker W. W., Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens: V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis. Laboratory Investigation 1978 38 4 502 510 2-s2.0-0018103501 (Pubitemid 8338244)
76. Couser W. G., Steinmuller D. R., Stilmant M. M., Experimental glomerulonephritis in the isolated perfused rat kidney. Journal of Clinical Investigation 1978 62 6 1275 1287 2-s2.0-0018133117 (Pubitemid 9075757)
77. Chen J. S., Chen A., Chang L. C., Chang W. S. W., Lee H. S., Lin S. H., Lin Y. F., Mouse model of membranous nephropathy induced by cationic bovine serum albumin: antigen dose-response relations and strain differences. Nephrology Dialysis Transplantation 2004 19 11 2721 2728 2-s2.0-8344272045 10.1093/ndt/gfh419 (Pubitemid 39480964)
78. Ronco P., Debiec H., Advances in membranous nephropathy: success stories of a long journey. Clinical and Experimental Pharmacology and Physiology 2011 38 7 410 416 2-s2.0-79959765686 10.1111/j.1440-1681.2011.05527.x
79. Beck L. H. Jr., Bonegio R. G. B., Lambeau G., Beck D. M., Powell D. W., Cummins T. D., Klein J. B., Salant D. J., M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. The New England Journal of Medicine 2009 361 1 11 21 2-s2.0-67649658244 10.1056/NEJMoa0810457
80. Espinosa-Hernandez M., Ortega-Salas R., López-Andreu M., C4d as a diagnostic tool in membranous nephropathy. Nefrologia 2012 32 3 295 299 10.3265/Nefrologia.pre2012.Feb.11224